Jul 15, 1991 - Robertson FW, Cumming AM. Effects of apoprotein B poly- morphism on serum ... J.Pesce, H. Brian HaIsall,â3 and William. R. Heinemanâ3.
E polymorphism and hyperlipidemia in type II diabetics. Diabetes 1987;35:1374-82. 33. Utermann G, Hees M. Broad-beta disease: genetic gene fre-
l’apoproteine E (ape B) et lipides seriques des diab#{233}tiques. Schweis Med Wochenschr 1987;117:2021-4. 23. Black SC, Hewett S, Kotubi Y, Brunt RV, Reckless JPD.
Apolipoprotein
Isoform patterns
quency
of apolipoprotein
B in diabetes
Med 1990;7:532-9. 24. Albers JJ, Hazzard WR. Immunochemical
mellitus.
Diab
quantification of
human plasma Lp(a) lipoproteun. Lipids 1974;9:15-26. 25. Wieland H, Seidel D. Fortschritte in der Analytik des Lipoproteunmusters. Inn Med 1978;5:290-6. 26. Kane YW, Gowland E. A method for the identification of apelipoprotein E isoforms employing chemical precipitation and flat bed isoelectric focusing in agarose. Ann Cliii Biochem 198623:509-13. 27. Scanu AM, Edelatein C. Solubility in aqueous solutions of ethanol of the small molecular weight peptides of the serum very low density and high density lipoproteins. Anal Biochem 1971;44:576-88. 28. Saudek CD, Eder HA. Lipid metabolism in diabetes mellitus.
Am
and diagnosis without ultracentrifugation. In: Radola BJ, D, eds. Proc. Intl. Symp. on Electrofocusing Isotachophoresis. Berlin 1977:281-93. 34. Warnick GR, Albers JJ, Hazzard WR. Genetics of type III hyperlipoproteinemia pseudodominant transmission in a large kindred. Circulation 1977;56:72-6. 35. Sano R, Abe R, Oikava S, Fujii Y, Toyota T. Apo E-2/E-3 ratio of very low density lipoprotein in diabetes mellitus. Toholu Y Exp Med 1985;146:131-6. 36. Wottawa A, Fromme K, Klein G. Lipoprotein(a) bei kororiarer Herzkrankheit und Myokardinfarkt. Munch Med Wochenschr Gresalin
J Med 1979;66:843-52.
29. Gabor J, Spain M, Kalant N. Composition of serum very low density and high density lipoproteins in diabetes. Clin Chem
1980;26:1261-9. 30. Goldberg RB. Lipid disorders in diabetes. Diabetes Care 1981; 4:561-72. 31. Robertson FW, Cumming AM. Effects of apoprotein B polymorphism on serum lipoprotein concentration. Arteriosclerosis 1985;5:283-92. 32. Eto M, Watanabe K, Iwashima Y, Morikawa A, Oshima E.
1984;126:53-5. 37. Shriever H, Assmann G, Sandkamp M. The relationship of lipoprotein(a) Lp(a) to risk factors of coronary heart disease. J Clin Chem Clin Biochem 1984;22:591-6. 38. Koltringer P, Jurgens G. A dominant role of lipoprotein(a) in the investigation and evaluation of parameters indicating the development of cervical atherosclerosis. Atherosclerosis 1985;58:187-98. 39. Mertz DP, B#{252}rvenich K Lipoprotein Lp(a) bei Diabetes mellitus Typ II. Med Welt 1985;3:895-8. 40. Mertz DP, Thuliot C, Saermann I. Lipoprotein Lp(a) at dietetic and pharmacologic intervention in hyper-LDL-cholesterinemia. Med Welt 1984;35:1050-5.
CUN. CHEM.39/7, 1432-1434 (1993)
Electrochemical Homogeneous Enzyme Immunoassay of Theophylline in Hemolyzed, Icteric, and Lipemic Samples Haiou
Yao,’
Sarah
We demonstrate
H. Jenkins,2
Amadeo
J.Pesce,
H. Brian
here an electrochemical homogeneous
enzyme immunoassay for theophylline, which can be performed in hemolyzed, lipemic, and ictenc samples. The assay used an unmodified Syva EMIT” theophylline kit.
One of the enzymatic reaction products, NADH, reacted with 2,6-dichloroindophenol (DCIP) to reduce DCIP to DCIPH2, which was detected electrochemically with flowinjection analysis. The inter- and intraassay coefficients of variation of this manual technique were
